119 related articles for article (PubMed ID: 37625279)
21. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
22. miR-9-5p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting ID4.
Zhu K; Lin J; Chen S; Xu Q
Technol Cancer Res Treat; 2021; 20():15330338211048592. PubMed ID: 34723712
[No Abstract] [Full Text] [Related]
23. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
Seidl C; Panzitt K; Bertsch A; Brcic L; Schein S; Mack M; Leithner K; Prinz F; Olschewski H; Kornmueller K; Hrzenjak A
Cancer Lett; 2020 Jan; 469():266-276. PubMed ID: 31697978
[TBL] [Abstract][Full Text] [Related]
25. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
[TBL] [Abstract][Full Text] [Related]
27. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
[TBL] [Abstract][Full Text] [Related]
28. Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin.
Wang Y; Zhang T; Du H; Yang M; Xie G; Liu T; Deng S; Yuan W; He S; Wu D; Xu Y
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37449493
[TBL] [Abstract][Full Text] [Related]
29. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
Wang L; Shang X; Feng Q
Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
[TBL] [Abstract][Full Text] [Related]
30. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
[TBL] [Abstract][Full Text] [Related]
31. miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin.
Chen X; Jiang Y; Huang Z; Li D; Chen X; Cao M; Meng Q; Pang H; Sun L; Zhao Y; Cai L
Sci Rep; 2016 Jan; 6():19455. PubMed ID: 26781643
[TBL] [Abstract][Full Text] [Related]
32. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
[TBL] [Abstract][Full Text] [Related]
33. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
34. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
[TBL] [Abstract][Full Text] [Related]
35. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
36. MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells.
Luo J; Xia L; Zhang L; Zhao K; Li C
Mutat Res; 2022; 825():111798. PubMed ID: 36087462
[TBL] [Abstract][Full Text] [Related]
37. [MiR-192 confers cisplatin resistance by targeting Bim in lung cancer].
Zhang F; Li Y; Wu H; Qi K; You J; Li X; Zu L; Pan Z; Wang Y; Li Y; Li Y; Wang M; Shen W; Zhou Q
Zhongguo Fei Ai Za Zhi; 2014 May; 17(5):384-90. PubMed ID: 24854555
[TBL] [Abstract][Full Text] [Related]
38. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
[TBL] [Abstract][Full Text] [Related]
39.
Jiang F; Shen Q; Zhang F; Fu J; Hu L; Wang J; Zhou H; Chen J; Wang Y
DNA Cell Biol; 2022 Jun; 41(6):631-640. PubMed ID: 35612423
[TBL] [Abstract][Full Text] [Related]
40. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]